KASO

Abiraterone acetate 250 mg tablets are primarily used in the treatment of prostate cancer, specifically in cases of metastatic castration-resistant prostate cancer (mCRPC) and metastatic high-risk castration-sensitive prostate cancer (mCSPC). This medication works by inhibiting the enzyme CYP17, which is involved in testosterone production.